What is Pharm Cbd?
Pharm Cbd operates as a vertically integrated, family-owned enterprise dedicated to the production and distribution of premium wellness solutions. The company leverages a diverse portfolio of hemp, mushroom, and botanical-derived products, ranging from USDA-certified organic beverages and tinctures to specialized topicals and pet care formulations. By prioritizing clean-label manufacturing and rigorous quality assurance protocols, Pharm Cbd has carved out a distinct market position that emphasizes efficacy and consumer trust. Their commitment to transparency is further evidenced by a robust customer satisfaction framework, which serves as a cornerstone for their direct-to-consumer growth strategy.
How much funding has Pharm Cbd raised?
Pharm Cbd has raised a total of $139K across 1 funding round:
Debt
$139K
Debt (2021): $139K with participation from PPP
Key Investors in Pharm Cbd
PPP
Public-Private Partnership
What's next for Pharm Cbd?
Following this major strategic investment, Pharm Cbd is well-positioned to accelerate its market penetration and operational infrastructure. The capital will likely be deployed to enhance supply chain resilience, expand product research and development, and scale distribution channels to meet the rising demand for high-quality botanical supplements. As the company transitions through this late-stage growth phase, the focus will shift toward optimizing customer acquisition costs and strengthening brand equity in an increasingly crowded wellness landscape. By maintaining its core focus on organic integrity and product consistency, Pharm Cbd is poised to capture a larger share of the health-conscious consumer demographic while navigating the complexities of the evolving regulatory environment.
See full Pharm Cbd company page
